Invention Grant
- Patent Title: Reduction of post-surgery cancer metastasis by combination of cannabidiol and NR2F6 inhibition
-
Application No.: US17037284Application Date: 2020-09-29
-
Publication No.: US11712474B2Publication Date: 2023-08-01
- Inventor: Thomas Ichim , David Koos
- Applicant: Regen Biopharma, Inc.
- Applicant Address: US MN Medina
- Assignee: Regen Biopharma, Inc.
- Current Assignee: Regen Biopharma, Inc.
- Current Assignee Address: US CA La Mesa
- Agency: Baumgartner Patent Law
- Agent Marc Baumgartner
- Main IPC: A61K45/06
- IPC: A61K45/06 ; A61K9/00 ; A61K31/352 ; C12Q1/6811 ; A61K31/05 ; A61K31/7088 ; A61K31/7105 ; A61K31/713

Abstract:
Disclosed are means of stimulating systemic immunity and reduction of post-surgery tumor metastasis through the concurrent intralymphatic inhibition of NR2F6 and treatment with cannabidiol. In some embodiments NR2F6 is inhibited by high pressure transient delivery of short interfering RNA into tumor draining lymph nodes concurrent with systemic administration of cannabidiol. This combination may be performed together with means that induce immunogenic tumor cell death. Through the combination of immunogenic cell death and immune stimulation, the invention provides a means of enhancing the abscopal effect and in some embodiments to cause immunological mediated destruction primary and secondary neoplasia.
Public/Granted literature
- US20210353755A1 REDUCTION OF POST-SURGERY CANCER METASTASIS BY COMBINATION OF CANNABIDIOL AND NR2F6 INHIBITION Public/Granted day:2021-11-18
Information query